These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 16965419)
1. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419 [TBL] [Abstract][Full Text] [Related]
2. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index. Berth-Jones J; Thompson J; Papp K; Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187 [TBL] [Abstract][Full Text] [Related]
3. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. Langley RG; Ellis CN J Am Acad Dermatol; 2004 Oct; 51(4):563-9. PubMed ID: 15389191 [TBL] [Abstract][Full Text] [Related]
4. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610 [TBL] [Abstract][Full Text] [Related]
5. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Bożek A; Reich A Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583 [TBL] [Abstract][Full Text] [Related]
7. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment. Chow C; Simpson MJ; Luger TA; Chubb H; Ellis CN J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1406-14. PubMed ID: 25917315 [TBL] [Abstract][Full Text] [Related]
8. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. Gottlieb AB; Chaudhari U; Baker DG; Perate M; Dooley LT J Drugs Dermatol; 2003 Jun; 2(3):260-6. PubMed ID: 12848110 [TBL] [Abstract][Full Text] [Related]
9. Interobserver reliability of the Nail Psoriasis Severity Index. Aktan S; Ilknur T; Akin C; Ozkan S Clin Exp Dermatol; 2007 Mar; 32(2):141-4. PubMed ID: 17137477 [TBL] [Abstract][Full Text] [Related]
10. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased. Jacobson CC; Kimball AB Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545 [TBL] [Abstract][Full Text] [Related]
11. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment. Simpson MJ; Chow C; Morgenstern H; Luger TA; Ellis CN J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1415-20. PubMed ID: 25917214 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of the Dermatomyositis Skin Severity Index. Carroll CL; Lang W; Snively B; Feldman SR; Callen J; Jorizzo JL Br J Dermatol; 2008 Feb; 158(2):345-50. PubMed ID: 18067478 [TBL] [Abstract][Full Text] [Related]
13. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. Puzenat E; Bronsard V; Prey S; Gourraud PA; Aractingi S; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Paul C; Richard-Lallemand MA; Ortonne JP; Aubin F J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():10-6. PubMed ID: 20443995 [TBL] [Abstract][Full Text] [Related]
14. Measurement of the severity of rosacea. Bamford JT; Gessert CE; Renier CM J Am Acad Dermatol; 2004 Nov; 51(5):697-703. PubMed ID: 15523346 [TBL] [Abstract][Full Text] [Related]
15. Method of assessing involved facial areas: rule of fours. Yoon HS; Choi JW; Youn JI Br J Dermatol; 2008 May; 158(5):1022-8. PubMed ID: 18341660 [TBL] [Abstract][Full Text] [Related]
16. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension. van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365 [TBL] [Abstract][Full Text] [Related]
17. Inter-observer reliability of the PASI in a clinical setting. Cabrera S; Chinniah N; Lock N; Cains GD; Woods J Australas J Dermatol; 2015 May; 56(2):100-2. PubMed ID: 25753553 [TBL] [Abstract][Full Text] [Related]
18. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760 [TBL] [Abstract][Full Text] [Related]
19. Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. Arkachaisri T; Pino S J Rheumatol; 2008 Apr; 35(4):650-7. PubMed ID: 18322985 [TBL] [Abstract][Full Text] [Related]
20. Inter-rater reliability of the Hamilton Depression Rating Scale as a diagnostic and outcome measure of depression in primary care. Morriss R; Leese M; Chatwin J; Baldwin D; J Affect Disord; 2008 Dec; 111(2-3):204-13. PubMed ID: 18374987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]